New Real-World Data Show Potential of Trilaciclib to Reduce the Substantial Burden of Myelosuppression in Patients with Extensive-Stage Small-Cell Lung Cancer Treated with Chemotherapy
Data being presented at the National Comprehensive Cancer Network (NCCN) 2022 Annual Conference March 31, 2022 16:05 ET | Source: G1 Therapeutics RESEARCH TRIANGLE PARK, N.C., March 31, 2022 (GLOBE NEWSWIRE) —...